CDKN2A and prostate cancer: Given the prevalent role of androgen signaling in prostate cancer initiation and progression, we generated R26hARL/wt:p16L/L: PB-Cre4 compound mice, where conditional expression of the human AR transgene and deletion of p16Ink4a co-occur in prostatic luminal epithelial cells.